🔗 Share this article Social Media Content Creators Fueling Unofficial Trade for Unapproved Slimming Drug A shadow economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations. Investigational Drug Acquiring Popularity Via Social Media The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these accounts directly for source information, while also receiving discount codes. Thriving Trade on Social Networks Additionally, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for transactions. Understanding Retatrutide Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic. Healthcare Experts Express Concerns However, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could lead to users administering substances of uncertain source. Some professionals said the popularity for the experimental drug could be connected to the rising cost of approved slimming treatments such as Mounjaro. Regulatory Position and Enforcement Marketing retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations. Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, risking fines, legal action or imprisonment. Service Response and Content Elimination According to the social media company, the service has removed violative content and banned related keywords and search suggestions. The company said it was dedicated to keeping the platform secure and investing in enhancing compliance measures. Digital Marketplace Activities Investigations also found groups with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up channels with numerous of members, populated with photos of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home. Within moments of entering one community, a seller posted WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about weight, health issues or previous experience. Product Information and Pricing Inside these groups, messages display dark colored packages with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”. Service Moderation and Safety Measures A representative for Telegram stated it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”. Medical Expert Warnings “Individuals are injecting substances they can’t verify. Even if the science behind this drug is valid, these digital products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was clean,” she said. Her staff has already seen individuals harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.” Manufacturer Position A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to potentially serious health risks”.